Skip to main content
Top
Published in: Pediatric Nephrology 7/2017

01-07-2017 | Original Article

The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch–Schönlein purpura nephritis

Authors: Mikael Koskela, Elisa Ylinen, Elli-Maija Ukonmaanaho, Helena Autio-Harmainen, Päivi Heikkilä, Jouko Lohi, Outi Jauhola, Jaana Ronkainen, Timo Jahnukainen, Matti Nuutinen

Published in: Pediatric Nephrology | Issue 7/2017

Login to get access

Abstract

Background

Histological findings from primary kidney biopsies were correlated with patient outcomes in a national cohort of paediatric Henoch–Schönlein nephritis (HSN) patients.

Methods

Primary kidney biopsies from 53 HSN patients were re-evaluated using the ISKDC (International Study of Kidney Disease in Children) classification and a modified semiquantitative classification (SQC) that scores renal findings and also takes into account activity, chronicity and tubulointerstitial indices. The ISKDC and SQC classifications were evaluated comparatively in four outcome groups: no signs of renal disease (outcome A, n = 27), minor urinary abnormalities (outcome B, n = 18), active renal disease (outcome C, n = 3) and renal insufficiency, end-stage renal disease or succumbed due to HSN (outcome D, n = 5). For the receiver operating characteristic and logistic regression analyses, outcomes A and B were considered to be favourable and outcomes C and D to be unfavourable. The median follow-up time was 7.3 years.

Results

The patients with an unfavourable outcome (C and D), considered together due to low patient numbers, had significantly higher total biopsy SQC scores and activity indices than those who had a favourable one (groups A and B). The chronicity and tubulointerstitial indices differed significantly only between group C + D and group A. The difference in areas under the curve between the total biopsy SQC scores and ISKDC findings was 0.15 [p = 0.04, normal-based 95% confidence interval (CI) 0.007–0.29, bias-controlled 95% CI −0.004 to 0.28].

Conclusions

Our results suggest that the modified SQC is more sensitive than ISKDC classification for predicting the outcome in HSN cases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch–SchonleinSchönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197–1202CrossRefPubMed Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch–SchonleinSchönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197–1202CrossRefPubMed
2.
3.
go back to reference Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch–SchonleinSchönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916–920CrossRefPubMedPubMedCentral Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch–SchonleinSchönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916–920CrossRefPubMedPubMedCentral
4.
go back to reference Davin JC (2011) Henoch–SchonleinSchönlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679–689CrossRefPubMed Davin JC (2011) Henoch–SchonleinSchönlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679–689CrossRefPubMed
5.
go back to reference Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch–SchonleinSchönlein nephritis in children. Br Med J 2:11–14CrossRefPubMedPubMedCentral Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch–SchonleinSchönlein nephritis in children. Br Med J 2:11–14CrossRefPubMedPubMedCentral
6.
go back to reference Davin JC, Coppo R (2013) Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch–SchonleinSchönlein purpura nephritis. Pediatr Nephrol 28:1897–1903CrossRefPubMed Davin JC, Coppo R (2013) Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch–SchonleinSchönlein purpura nephritis. Pediatr Nephrol 28:1897–1903CrossRefPubMed
7.
go back to reference Ronkainen J, Ala-Houhala M, Autio-Harmainen H, Jahnukainen T, Koskimies O, Merenmies J, Mustonen J, Ormala T, Turtinen J, Nuutinen M (2006) Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study. Pediatr Nephrol 21:1266–1273CrossRefPubMed Ronkainen J, Ala-Houhala M, Autio-Harmainen H, Jahnukainen T, Koskimies O, Merenmies J, Mustonen J, Ormala T, Turtinen J, Nuutinen M (2006) Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study. Pediatr Nephrol 21:1266–1273CrossRefPubMed
8.
go back to reference Jauhola O, Ronkainen J, Autio-Harmainen H, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, Jahnukainen T, Rajantie J, Ormala T, Nuutinen M (2011) Cyclosporine A vs. methylprednisolone for Henoch–SchonleinSchönlein nephritis: a randomized trial. Pediatr Nephrol 26:2159–2166CrossRefPubMed Jauhola O, Ronkainen J, Autio-Harmainen H, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, Jahnukainen T, Rajantie J, Ormala T, Nuutinen M (2011) Cyclosporine A vs. methylprednisolone for Henoch–SchonleinSchönlein nephritis: a randomized trial. Pediatr Nephrol 26:2159–2166CrossRefPubMed
9.
go back to reference Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedPubMedCentral
10.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, 3rd Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, 3rd Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
12.
go back to reference Goldstein AR, White RH, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch–SchonleinSchönlein nephritis. Lancet 339:280–282CrossRefPubMed Goldstein AR, White RH, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch–SchonleinSchönlein nephritis. Lancet 339:280–282CrossRefPubMed
13.
go back to reference Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood purpura: a retrospective cohort study. Lancet 360:666–670CrossRefPubMed Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood purpura: a retrospective cohort study. Lancet 360:666–670CrossRefPubMed
14.
go back to reference Nuutinen M, Lautala P, Remes M, Uhari M (2000) Nephrectomy in severe hypertension. Clin Nephrol 54:342–346PubMed Nuutinen M, Lautala P, Remes M, Uhari M (2000) Nephrectomy in severe hypertension. Clin Nephrol 54:342–346PubMed
15.
go back to reference Pepe MS, Longton G, Janes H (2009) Estimation and comparison of receiver operating characteristic curves. Stata J 9:1–16PubMedPubMedCentral Pepe MS, Longton G, Janes H (2009) Estimation and comparison of receiver operating characteristic curves. Stata J 9:1–16PubMedPubMedCentral
17.
go back to reference Cicchetti D (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6:284–290CrossRef Cicchetti D (1994) Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 6:284–290CrossRef
18.
go back to reference Edstrom Halling S, Soderberg MP, Berg UB (2010) Predictors of outcome in Henoch–SchonleinSchönlein nephritis. Pediatr Nephrol 25:1101–1108CrossRefPubMed Edstrom Halling S, Soderberg MP, Berg UB (2010) Predictors of outcome in Henoch–SchonleinSchönlein nephritis. Pediatr Nephrol 25:1101–1108CrossRefPubMed
19.
go back to reference Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, Ormala T, Nuutinen M (2003) Outcome of Henoch–SchonleinSchönlein nephritis with nephrotic-range proteinuria. Clin Nephrol 60:80–84CrossRefPubMed Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, Ormala T, Nuutinen M (2003) Outcome of Henoch–SchonleinSchönlein nephritis with nephrotic-range proteinuria. Clin Nephrol 60:80–84CrossRefPubMed
20.
go back to reference Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch–SchonleinSchönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375CrossRefPubMed Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch–SchonleinSchönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375CrossRefPubMed
21.
go back to reference Lim BJ, Shin JI, Choi SE, Rhim H, Lee JS, Kim PK, Jeong HJ, Kim JH (2016) The significance of tubulointerstitial lesions in childhood Henoch–SchonleinSchönlein nephritis. Pediatr Nephrol 31:2087–2093CrossRefPubMed Lim BJ, Shin JI, Choi SE, Rhim H, Lee JS, Kim PK, Jeong HJ, Kim JH (2016) The significance of tubulointerstitial lesions in childhood Henoch–SchonleinSchönlein nephritis. Pediatr Nephrol 31:2087–2093CrossRefPubMed
22.
go back to reference Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch–SchonleinSchönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271–1278CrossRefPubMed Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch–SchonleinSchönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271–1278CrossRefPubMed
23.
go back to reference Wakaki H, Ishikura K, Hataya H, Hamasaki Y, Sakai T, Yata N, Kaneko T, Honda M (2011) Henoch–SchonleinSchönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes. Pediatr Nephrol 26:921–925CrossRefPubMed Wakaki H, Ishikura K, Hataya H, Hamasaki Y, Sakai T, Yata N, Kaneko T, Honda M (2011) Henoch–SchonleinSchönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes. Pediatr Nephrol 26:921–925CrossRefPubMed
24.
go back to reference Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch–SchonleinSchönlein nephritis in children and adults. Am J Kidney Dis 47:993–1003CrossRefPubMed Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch–SchonleinSchönlein nephritis in children and adults. Am J Kidney Dis 47:993–1003CrossRefPubMed
25.
go back to reference Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Henoch–SchonleinSchönlein purpura nephritis. Pediatr Nephrol 12:238–243CrossRefPubMed Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Henoch–SchonleinSchönlein purpura nephritis. Pediatr Nephrol 12:238–243CrossRefPubMed
26.
go back to reference Kawasaki Y, Suzuki J, Suzuki H (2004) Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch–SchonleinSchönlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant 19:858–864CrossRefPubMed Kawasaki Y, Suzuki J, Suzuki H (2004) Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch–SchonleinSchönlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant 19:858–864CrossRefPubMed
27.
go back to reference Szeto CC, Choi PC, To KF, Li PK, Hui J, Chow KM, Leung CB, Lui SF, Mac-Moune Lai F (2001) Grading of acute and chronic renal lesions in Henoch–SchonleinSchönlein purpura. Mod Pathol 14:635–640CrossRefPubMed Szeto CC, Choi PC, To KF, Li PK, Hui J, Chow KM, Leung CB, Lui SF, Mac-Moune Lai F (2001) Grading of acute and chronic renal lesions in Henoch–SchonleinSchönlein purpura. Mod Pathol 14:635–640CrossRefPubMed
28.
go back to reference Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D’Agati V, D’Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556CrossRef Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D’Agati V, D’Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556CrossRef
29.
30.
go back to reference Kim CH, Lim BJ, Bae YS, Kwon YE, Kim YL, Nam KH, Park KS, An SY, Koo HM, Doh FM, Lee MJ, Oh HJ, Yoo TH, Kang SW, Choi KH, Jeong HJ, Han SH (2014) Using the oxford classification of IgA nephropathy to predict long-term outcomes of Henoch–SchonleinSchönlein purpura nephritis in adults. Mod Pathol 27:972–982CrossRefPubMed Kim CH, Lim BJ, Bae YS, Kwon YE, Kim YL, Nam KH, Park KS, An SY, Koo HM, Doh FM, Lee MJ, Oh HJ, Yoo TH, Kang SW, Choi KH, Jeong HJ, Han SH (2014) Using the oxford classification of IgA nephropathy to predict long-term outcomes of Henoch–SchonleinSchönlein purpura nephritis in adults. Mod Pathol 27:972–982CrossRefPubMed
31.
go back to reference Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch–SchonleinSchönlein purpura nephritis? Kidney Int 59:823–834CrossRefPubMed Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch–SchonleinSchönlein purpura nephritis? Kidney Int 59:823–834CrossRefPubMed
32.
go back to reference Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Henoch–SchonleinSchönlein purpura nephritis in children. Pediatr Nephrol 13:816–823CrossRefPubMed Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Henoch–SchonleinSchönlein purpura nephritis in children. Pediatr Nephrol 13:816–823CrossRefPubMed
33.
go back to reference Davin JC, Coppo R (2014) Henoch–SchonleinSchönlein purpura nephritis in children. Nat Rev Nephrol 10:563–573CrossRefPubMed Davin JC, Coppo R (2014) Henoch–SchonleinSchönlein purpura nephritis in children. Nat Rev Nephrol 10:563–573CrossRefPubMed
34.
go back to reference Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–SchonleinSchönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247CrossRefPubMed Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–SchonleinSchönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247CrossRefPubMed
35.
go back to reference Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, Jahnukainen T, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2010) Renal manifestations of Henoch–SchonleinSchönlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 95:877–882CrossRefPubMed Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Holtta T, Jahnukainen T, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2010) Renal manifestations of Henoch–SchonleinSchönlein purpura in a 6-month prospective study of 223 children. Arch Dis Child 95:877–882CrossRefPubMed
36.
go back to reference Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165:710–718CrossRefPubMed Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165:710–718CrossRefPubMed
Metadata
Title
The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch–Schönlein purpura nephritis
Authors
Mikael Koskela
Elisa Ylinen
Elli-Maija Ukonmaanaho
Helena Autio-Harmainen
Päivi Heikkilä
Jouko Lohi
Outi Jauhola
Jaana Ronkainen
Timo Jahnukainen
Matti Nuutinen
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 7/2017
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-017-3608-5

Other articles of this Issue 7/2017

Pediatric Nephrology 7/2017 Go to the issue